Invetech and MeMed Won 2026 Gold Good Design Award

The MeMed Key immunoassay platform earned top honors for its innovative engineering and diagnostic design.

Updated on Oct. 9, 2026 in Life Sciences

Isometric editorial illustration of a sleek, unbranded medical diagnostic pod on a clean clinical surface, representing point-of-care health technology innovation.
Invetech and MeMed won the 2026 Gold Good Design Award for their MeMed Key platform, which simplifies point-of-care diagnostic procedures for clinicians. AI Illustration. Upload story photo >

Live Poll

Do you believe rapid point-of-care diagnostic tools improve the quality of healthcare in your community?

Invetech and MeMed have secured a 2026 Gold Good Design Award for the MeMed Key platform in the Engineering Design category. The compact diagnostic tool is designed to quickly distinguish between bacterial and viral infections.

Why it matters

The platform addresses the critical clinical challenge of differentiating infection types to help medical professionals make timely and accurate treatment decisions. Its design simplifies complex diagnostic procedures into a compact, point-of-care system.

The system utilizes a panel of 80 international jurors to evaluate submissions based on excellence and innovation. The MeMed Key platform is capable of delivering diagnostic test results in as little as 15 minutes.

The players

Invetech

This company has operated for 40 years as a developer of diagnostic and biomedical instruments.

MeMed

This organization develops technology intended to improve clinical decision-making regarding infection management.

Frog Design

This firm specializes in industrial design, human factors engineering, and product innovation strategies.

The details

Invetech provided comprehensive engineering, manufacturing, and commercialization support to translate benchtop assay procedures into a portable format. Frog Design contributed to the industrial design and human factors engineering, ensuring the system functions effectively at the point of care.

Timeline

  1. Invetech and MeMed announced the award win on October 9, 2026.

The Big Picture

The recognition follows the standards of the 2026 Gold Good Design Award criteria, which prioritize high-level design excellence and societal impact. This achievement marks a shift toward prioritizing user-centric engineering in complex diagnostic systems.

The compact design of the MeMed Key platform could lead to faster diagnostic testing availability at local clinics in San Diego. By simplifying complex procedures, it may reduce the time patients spend waiting for results to determine if they need antibiotics.

The takeaway

This award highlights how cross-disciplinary collaboration between engineers and designers can improve clinical workflows. Implementing portable diagnostic tools at the point of care can significantly speed up treatment pathways for patients.

Further reading

Learn more about the latest innovations in Life Sciences.

Source note: This article includes information reported by The Queenslander.

Live Poll

Do you believe rapid point-of-care diagnostic tools improve the quality of healthcare in your community?